Helix BioPharma (HBP) Competitors C$0.97 0.00 (0.00%) As of 07/11/2025 09:34 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock HBP vs. BCT, IPA, TH, SCYB, COM, NVH, ONC, IGX, COV, and MDNAShould you be buying Helix BioPharma stock or one of its competitors? The main competitors of Helix BioPharma include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Theratechnologies (TH), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), Oncolytics Biotech (ONC), IntelGenx Technologies (IGX), Covalon Technologies (COV), and Medicenna Therapeutics (MDNA). These companies are all part of the "biotechnology" industry. Helix BioPharma vs. Its Competitors BriaCell Therapeutics ImmunoPrecise Antibodies Theratechnologies Scythian Biosciences 138267 (COM.TO) Novoheart Oncolytics Biotech IntelGenx Technologies Covalon Technologies Medicenna Therapeutics Helix BioPharma (TSE:HBP) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations. Is HBP or BCT more profitable? Helix BioPharma's return on equity of 1,803.57% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Helix BioPharmaN/A 1,803.57% -279.98% BriaCell Therapeutics N/A N/A N/A Which has higher earnings & valuation, HBP or BCT? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Helix BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHelix BioPharmaN/AN/A-C$50.55M-C$0.95-1.02BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19 Does the media refer more to HBP or BCT? In the previous week, BriaCell Therapeutics had 2 more articles in the media than Helix BioPharma. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 0 mentions for Helix BioPharma. Helix BioPharma's average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -0.27 indicating that Helix BioPharma is being referred to more favorably in the media. Company Overall Sentiment Helix BioPharma Neutral BriaCell Therapeutics Neutral SummaryHelix BioPharma and BriaCell Therapeutics tied by winning 3 of the 6 factors compared between the two stocks. Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HBP vs. The Competition Export to ExcelMetricHelix BioPharmaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$51.43MC$129.27MC$5.56BC$6.20BDividend Yield1.50%3.74%5.06%6.72%P/E Ratio-1.023.4728.2650.47Price / SalesN/A4,141.03437.101,211.67Price / Cash11.3213.1937.1283.29Price / Book-6.9742.088.044.70Net Income-C$50.55M-C$92.15MC$3.19BC$301.20M7 Day PerformanceN/A1.37%3.62%1.05%1 Month PerformanceN/A5.67%5.98%4.15%1 Year Performance321.74%169.31%29.39%25.91% Helix BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBPHelix BioPharmaN/AC$0.97flatN/A+321.7%C$51.43MN/A-1.029BCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195News CoverageIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap DownTHTheratechnologiesN/AC$4.23+31.8%N/A+118.3%C$134.96MC$52.22M-47.88103High Trading VolumeSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423.50K-13.95N/AONCOncolytics Biotech1.0638 of 5 starsC$1.24+18.1%C$3.50+182.3%+11.1%C$95.57MN/A-3.4529Analyst RevisionHigh Trading VolumeIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpCOVCovalon TechnologiesN/AC$2.60+6.6%N/A+31.7%C$71.24MC$27.87M29.84N/ANews CoverageGap UpMDNAMedicenna TherapeuticsN/AC$0.90+3.4%N/A-60.7%C$67.33MC$4.87K-2.4820Gap Up Related Companies and Tools Related Companies BriaCell Therapeutics Competitors ImmunoPrecise Antibodies Competitors Theratechnologies Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors Oncolytics Biotech Competitors IntelGenx Technologies Competitors Covalon Technologies Competitors Medicenna Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:HBP) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HBP Stock Alerts